Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Arrhythmias

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 87 articles:
HTML format



Single Articles


    March 2024
  1. DE COSTER T, Teplenin AS, Feola I, Bart CI, et al
    'Trapped re-entry' as source of acute focal atrial arrhythmias.
    Cardiovasc Res. 2024;120:249-261.
    PubMed     Abstract available


  2. TONKO JB, Lambiase PD
    The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Cardiovasc Res. 2024;120:114-131.
    PubMed     Abstract available


    February 2024
  3. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    


  4. HARDING D, Fanti S, Marelli-Berg F
    Tumour necrosis factor-alpha in cardiac inflammation: friend or foe?
    Cardiovasc Res. 2024;120:1-2.
    PubMed    


  5. HEIJMAN J, Madreiter-Sokolowski CT
    Is ageing a modifiable risk factor for atrial fibrillation?
    Cardiovasc Res. 2024 Feb 26:cvae040. doi: 10.1093.
    PubMed    


  6. FABRITZ L, Lemoine MD
    Atrial fibrillation in the young: consider heritable conditions like short QT syndrome.
    Cardiovasc Res. 2024 Feb 22:cvae041. doi: 10.1093.
    PubMed    


  7. VELASCO JJ, Akar FG
    A new year's resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodeling.
    Cardiovasc Res. 2024 Feb 22:cvae039. doi: 10.1093.
    PubMed    


  8. MURPHY MB, Yang Z, Subati T, Farber-Eger E, et al
    LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Cardiovasc Res. 2024 Feb 20:cvae036. doi: 10.1093.
    PubMed     Abstract available


  9. ROGERS AJ, Narayan SM
    Latent drivers for atrial fibrillation and specific patterns of localized fibrosis.
    Cardiovasc Res. 2024 Feb 20:cvae032. doi: 10.1093.
    PubMed    


    January 2024
  10. NGUYEN MN, Hooper C, Stefanini M, Vrellaku B, et al
    Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
    Cardiovasc Res. 2024 Jan 25:cvae022. doi: 10.1093.
    PubMed     Abstract available


  11. MORENO-MANUEL AI, Macias A, Cruz FM, Gutierrez LK, et al
    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3.
    Cardiovasc Res. 2024 Jan 23:cvae019. doi: 10.1093.
    PubMed     Abstract available


  12. SHI Q, Malik H, Crawford RM, Streeter J, et al
    Cardiac MAO-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.
    Cardiovasc Res. 2024 Jan 10:cvae012. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  13. DOREY TW, McRae MD, Belke DD, Rose RA, et al
    PDE4D mediates impaired beta-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease.
    Cardiovasc Res. 2023;119:2697-2711.
    PubMed     Abstract available


  14. OLCUM M, Fan S, Rouhi L, Cheedipudi S, et al
    Genetic inactivation of beta-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Cardiovasc Res. 2023;119:2712-2728.
    PubMed     Abstract available


  15. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  16. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    PubMed     Abstract available


  17. JONES CA, Wallace MJ, Bandaru P, Woodbury ED, et al
    E-cigarettes and arrhythmogenesis: a comprehensive review of pre-clinical studies and their clinical implications.
    Cardiovasc Res. 2023;119:2157-2164.
    PubMed     Abstract available


    September 2023
  18. VENKATESHAPPA R, Hunter DV, Muralidharan P, Nagalingam RS, et al
    Targeted activation of hERG channels rescues electrical instability induced by the hERG R56Q+/- Long QT Syndrome variant.
    Cardiovasc Res. 2023 Sep 21:cvad155. doi: 10.1093.
    PubMed     Abstract available


  19. LAKIN R, Polidovitch N, Yang S, Parikh M, et al
    Cardiomyocyte and endothelial cells play distinct roles in the tumor necrosis factor (TNF)-dependent atrial responses and increased atrial fibrillation vulnerability induced by endurance exercise training in mice.
    Cardiovasc Res. 2023 Sep 15:cvad144. doi: 10.1093.
    PubMed     Abstract available


  20. SEIBERTZ F, Rubio T, Springer R, Popp F, et al
    Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
    Cardiovasc Res. 2023 Sep 7:cvad143. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  21. BOURIER F, Schunkert H
    Has genetic disposition implications for treatment decisions in atrial fibrillation?
    Cardiovasc Res. 2023 Jul 5:cvad098. doi: 10.1093.
    PubMed    


  22. MARCHAL GA, Galjart N, Portero V, Remme CA, et al
    Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis.
    Cardiovasc Res. 2023;119:1461-1479.
    PubMed     Abstract available


    June 2023
  23. KANY S, Al-Taie C, Roselli C, Pirruccello JP, et al
    Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Cardiovasc Res. 2023 Jun 2:cvad027. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  24. MORENO-MANUEL AI, Gutierrez LK, Vera-Pedrosa ML, Cruz FM, et al
    Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
    Cardiovasc Res. 2023;119:919-932.
    PubMed     Abstract available


    March 2023
  25. MCKAY M, Akar FG
    A unifying mechanism for the initiation of torsade de pointes: blurring the distinction between trigger and substrate.
    Cardiovasc Res. 2023;119:333-335.
    PubMed    


  26. BOOGERD CJ, Lacraz GPA, Vertesy A, van Kampen SJ, et al
    Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
    Cardiovasc Res. 2023;119:477-491.
    PubMed     Abstract available


  27. CAMPOSTRINI G, Kosmidis G, Ward-van Oostwaard D, Davis RP, et al
    Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
    Cardiovasc Res. 2023;119:167-182.
    PubMed     Abstract available


  28. PARKSOOK WW, Williams GH
    Aldosterone and cardiovascular diseases.
    Cardiovasc Res. 2023;119:28-44.
    PubMed     Abstract available


  29. VARDAS PE
    Large-scale digital population screening for atrial fibrillation: swinging around the uncertainties.
    Cardiovasc Res. 2023 Mar 3:cvad032. doi: 10.1093.
    PubMed    


    January 2023
  30. NINNI S, Nattel S
    Factor XIa inhibition in atrial fibrillation: insights and knowledge gaps emerging from the PACIFIC-AF trial.
    Cardiovasc Res. 2023 Jan 25:cvac196. doi: 10.1093.
    PubMed    


    December 2022
  31. GIACCA M
    Gene editing for cardiomyopathy takes a step forward.
    Cardiovasc Res. 2022;118:3011-3012.
    PubMed    


  32. SUFFEE N, Baptista E, Piquereau J, Ponnaiah M, et al
    Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice.
    Cardiovasc Res. 2022;118:3126-3139.
    PubMed     Abstract available


    October 2022
  33. TOW BD, Deb A, Neupane S, Patel SM, et al
    SR-Mitochondria Crosstalk Shapes Ca Signalling to Impact Pathophenotype in Disease Models Marked by Dysregulated Intracellular Ca Release.
    Cardiovasc Res. 2022;118:2819-2832.
    PubMed     Abstract available


    July 2022
  34. NYNS ECA, Jin T, Fontes MS, van den Heuvel T, et al
    Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.
    Cardiovasc Res. 2022;118:2293-2303.
    PubMed     Abstract available


  35. KEEFE J, Wehrens XH, Dobrev D
    Common disease-promoting signaling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences.
    Cardiovasc Res. 2022 Jul 5. pii: 6631397. doi: 10.1093.
    PubMed    


    June 2022
  36. CHAUMONT C, Suffee N, Gandjbakhch E, Balse E, et al
    Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology.
    Cardiovasc Res. 2022;118:1693-1702.
    PubMed     Abstract available


  37. ALEXANDER C, Bishop MJ, Gilchrist RJ, MRes BA, et al
    Initiation of ventricular arrhythmia in the acquired long QT syndrome.
    Cardiovasc Res. 2022 Jun 21. pii: 6612700. doi: 10.1093.
    PubMed     Abstract available


  38. GAWALKO M, Saljic A, Li N, Abu-Taha I, et al
    Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance.
    Cardiovasc Res. 2022 Jun 11. pii: 6605797. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  39. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
    The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Cardiovasc Res. 2022;118:1466-1478.
    PubMed     Abstract available


    April 2022
  40. LIUTKUTE A, Brundel BJ, Voigt N
    Not the classical serendipity: does doxapram treat atrial fibrillation?
    Cardiovasc Res. 2022 Apr 15. pii: 6568887. doi: 10.1093.
    PubMed    


  41. FARINHA JM, Gupta D, Lip GYH
    Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation and stroke.
    Cardiovasc Res. 2022 Apr 7. pii: 6564589. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  42. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    PubMed     Abstract available


  43. PROIETTI R, Lip GYH, Akhtar R, Field M, et al
    Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways.
    Cardiovasc Res. 2022;118:e32-e35.
    PubMed    


  44. LOUCH WE
    A TRP to the emergency room: Understanding arrhythmia in the ageing heart.
    Cardiovasc Res. 2022;118:932-933.
    PubMed    


  45. PEANA D, Polo-Parada L, Domeier TL
    Arrhythmogenesis in the aged heart following ischaemia-reperfusion: role of transient receptor potential vanilloid 4.
    Cardiovasc Res. 2022;118:1126-1137.
    PubMed     Abstract available


    January 2022
  46. MACIAS A, Diaz-Larrosa JJ, Blanco Y, Fanjul V, et al
    Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Cardiovasc Res. 2022;118:503-516.
    PubMed     Abstract available


  47. BARC J, Ravens U
    Scientists on the Spot: Tracing the potential in electrophysiology.
    Cardiovasc Res. 2022;118:e6-e7.
    PubMed    


  48. JAYARAM R, Jones M, Reilly S, Crabtree MJ, et al
    Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin.
    Cardiovasc Res. 2022;118:184-195.
    PubMed     Abstract available


  49. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Publisher's note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2022 Jan 5. pii: 6498023. doi: 10.1093.
    PubMed    


    December 2021
  50. RAVENS U, Gomez AM, Heijman J, Remme CA, et al
    Edward Carmeliet (1930-2021)-channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiologydagger.
    Cardiovasc Res. 2021;117:e171-e173.
    PubMed    


  51. COPPINI R, Cerbai E
    Of hits, players, and goalkeepers: the case of arrhythmias in diabetes.
    Cardiovasc Res. 2021;117:2694-2695.
    PubMed    


  52. HATEM SN, Cohen A
    Atrial fibrillation and stroke: are we looking in the right direction?
    Cardiovasc Res. 2021 Dec 13. pii: 6460256. doi: 10.1093.
    PubMed    


    November 2021
  53. LI N, Durgan DJ, Wehrens XHT
    Gut microbiota - a key regulator of aging-associated atrial fibrillation?
    Cardiovasc Res. 2021 Nov 26. pii: 6443115. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  54. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    PubMed     Abstract available


  55. NI L, Lahiri SK, Nie J, Pan X, et al
    Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice.
    Cardiovasc Res. 2021 Oct 14. pii: 6396865. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  56. DOBREV D, Dudley SC
    Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?
    Cardiovasc Res. 2021;117:2291-2293.
    PubMed    


  57. GAWALKO M, Agbaedeng TA, Saljic A, Muller DN, et al
    Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.
    Cardiovasc Res. 2021 Sep 22. pii: 6373888. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  58. CAMPBELL H, Aguilar-Sanchez Y, Quick AP, Dobrev D, et al
    SPEG: a key regulator of cardiac calcium homeostasis.
    Cardiovasc Res. 2021;117:2175-2185.
    PubMed     Abstract available


  59. BALLOUZ S, Mangala MM, Perry MD, Heitmann S, et al
    Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
    Cardiovasc Res. 2021;117:2216-2227.
    PubMed     Abstract available


  60. DING WY, McDowell G, Lip GYH
    Utilising biomarkers in atrial fibrillation: the pros and cons.
    Cardiovasc Res. 2021 Aug 25. pii: 6357701. doi: 10.1093.
    PubMed    


  61. POL T, Hijazi Z, Lindback J, Oldgren J, et al
    Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Aug 6. pii: 6343453. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  62. HALL EJ, Pal S, Glennon MS, Shridhar P, et al
    Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.
    Cardiovasc Res. 2021 Jul 30. pii: 6332002. doi: 10.1093.
    PubMed     Abstract available


  63. AL SAYED ZR, Canac R, Cimarosti B, Bonnard C, et al
    Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Cardiovasc Res. 2021;117:2092-2107.
    PubMed     Abstract available


  64. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    PubMed     Abstract available


  65. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.
    PubMed    


  66. DERI S, Borbas J, Hartai T, Hategan L, et al
    Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
    Cardiovasc Res. 2021;117:1923-1934.
    PubMed     Abstract available


  67. RATHJENS FS, Blenkle A, Iyer LM, Renger A, et al
    Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
    Cardiovasc Res. 2021;117:1908-1922.
    PubMed     Abstract available


  68. ZHAO Y, James NA, Beshay AR, Chang EE, et al
    Adult zebrafish ventricular electrical gradients as tissue mechanisms of ECG patterns under baseline vs. oxidative stress.
    Cardiovasc Res. 2021;117:1891-1907.
    PubMed     Abstract available


    June 2021
  69. SCHOTTEN U
    From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
    Cardiovasc Res. 2021;117:e88-e90.
    PubMed    


  70. SCOTT L JR, Fender AC, Saljic A, Li L, et al
    NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.
    Cardiovasc Res. 2021;117:1746-1759.
    PubMed     Abstract available


  71. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    PubMed     Abstract available


  72. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2021;117:1-21.
    PubMed     Abstract available


  73. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    PubMed     Abstract available


  74. NATTEL S, Lip GYH, Filgueiras-Rama D, Dobrev D, et al
    Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation.
    Cardiovasc Res. 2021 Jun 4. pii: 6292088. doi: 10.1093.
    PubMed    


    May 2021
  75. CASADEI B, Sipido KR
    Calcium and postoperative atrial fibrillation: round up the usual suspects!
    Cardiovasc Res. 2021 May 29. pii: 6288489. doi: 10.1093.
    PubMed    


  76. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    PubMed     Abstract available


  77. HANNA P, Buch E, Stavrakis S, Meyer C, et al
    Neuroscientific Therapies for Atrial Fibrillation.
    Cardiovasc Res. 2021 May 14. pii: 6275748. doi: 10.1093.
    PubMed     Abstract available


  78. KANY S, Reissmann B, Metzner A, Kirchhof P, et al
    Genetics of atrial fibrillation - practical applications for clinical management: If not now, when and how?
    Cardiovasc Res. 2021 May 12. pii: 6274893. doi: 10.1093.
    PubMed     Abstract available


  79. OLIER I, Ortega-Martorell S, Pieroni M, Lip GYH, et al
    How machine learning is impacting research in atrial fibrillation: Implications for risk prediction and future management.
    Cardiovasc Res. 2021 May 12. pii: 6274894. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  80. HEIJMAN J, Sutanto H, Crijns HJGM, Nattel S, et al
    Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care.
    Cardiovasc Res. 2021 Apr 23. pii: 6247759. doi: 10.1093.
    PubMed     Abstract available


  81. HATEM SN
    Revealing the molecular history of the transition from paroxysmal to permanent atrial fibrillation.
    Cardiovasc Res. 2021 Apr 20. pii: 6241493. doi: 10.1093.
    PubMed    


    February 2021
  82. PROTONOTARIOS A, Marelli-Berg F
    Influenza-associated cardiac injury: a disease of the cardiac conduction system?
    Cardiovasc Res. 2021;117:643-644.
    PubMed    


  83. LEE YK, Sala L, Mura M, Rocchetti M, et al
    MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
    Cardiovasc Res. 2021;117:767-779.
    PubMed     Abstract available


    January 2021
  84. HEGYI B, Ko CY, Bossuyt J, Bers DM, et al
    Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycemia: reduced repolarization reserve, neurohormonal stimulation and heart failure exacerbate susceptibility.
    Cardiovasc Res. 2021 Jan 23. pii: 6105172. doi: 10.1093.
    PubMed     Abstract available


  85. RONCHI C, Bernardi J, Mura M, Stefanello M, et al
    NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Cardiovasc Res. 2021;117:472-483.
    PubMed     Abstract available


  86. GUICHARD JB, Xiong F, Qi XY, L'Heureux N, et al
    Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodelling.
    Cardiovasc Res. 2021;117:462-471.
    PubMed     Abstract available


    January 2020
  87. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.